CAP Responds to Request for Information on Consolidation in Health Care Markets ArticleJun 24, 2024 CAP Responds to Request for Information on Consolidation in Health Care Markets The Center for American Progress submitted a response to the U.S. Department of Justice, Federal Trade Commission, and U.S. Department of Health and Human Services’ request for information on consolidation in health care markets. Jun 24, 2024 Natasha Murphy, Nicole Rapfogel, Alexandra Thornton, 3 More Marc Jarsulic, Andrea Ducas, Brian Keyser
Project 2025 Would Take Away Access to Free Emergency Contraception for 48 Million Women ArticleJun 18, 2024 Project 2025 Would Take Away Access to Free Emergency Contraception for 48 Million Women A new state-by-state analysis estimates that 48 million women would lose guaranteed access to no-cost emergency contraception if the Project 2025 agenda were implemented. Jun 18, 2024 Nicole Rapfogel, Kierra B. Jones
Project 2025 Prescription Drug Plan Would Increase Costs for as Many as 18.5 Million Seniors and Others With Medicare ArticleJun 13, 2024 Project 2025 Prescription Drug Plan Would Increase Costs for as Many as 18.5 Million Seniors and Others With Medicare If Project 2025 is implemented, at least 1.5 million Medicare beneficiaries with high out-of-pocket costs will pay more for prescription drugs next year. Jun 13, 2024 Nicole Rapfogel
2024 Affordable Care Act Marketplace Plan Selections by Congressional District InteractiveMay 2, 2024 2024 Affordable Care Act Marketplace Plan Selections by Congressional District A new CAP interactive explores the proportion of nonelderly people who made federally facilitated marketplace plan selections during the 2024 open enrollment period by congressional district. Without congressional action, consumers will lose the enhanced financial assistance that supported record levels of enrollment. May 2, 2024 Nicole Rapfogel
Monthly Medicare Drug Price Negotiation Savings by State InteractiveApr 2, 2024 Monthly Medicare Drug Price Negotiation Savings by State Medicare drug price negotiation will result in thousands of dollars in net price savings for 30-day supplies of the first 10 drugs undergoing negotiation; here’s how those savings add up state by state. Apr 2, 2024 Nicole Rapfogel
5 Things To Know About Pharmacy Benefit Managers ArticleMar 13, 2024 5 Things To Know About Pharmacy Benefit Managers Pharmacy benefit managers are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. Mar 13, 2024 Nicole Rapfogel
Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month ArticleFeb 21, 2024 Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month A new analysis estimates prices for 30-day supplies of the first 10 Medicare Part D drugs undergoing price negotiations, with monthly reductions as high as $6,500 for some drugs. Feb 21, 2024 Nicole Rapfogel
Obamacare Has Been a Success, and It’s Just the Start In the NewsFeb 16, 2024 Obamacare Has Been a Success, and It’s Just the Start Nicole Rapfogel writes in The Ripon Forum about the benefits of the Affordable Care Act. Feb 16, 2024 The Ripon Forum Nicole Rapfogel
The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage ReportJan 25, 2024 The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage This report offers policy principles for employer public option reform to help reduce the cost of employer-sponsored insurance; lower health care prices; and increase workers’ access to affordable, comprehensive coverage. Jan 25, 2024 Natasha Murphy, Sam Hughes, Nicole Rapfogel
Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance ReportJan 25, 2024 Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance Federal policymakers should act to lower health insurance costs and improve affordability for both employers and workers. Jan 25, 2024 Sam Hughes, Nicole Rapfogel, Emily Gee
Drug Companies Continue To Hike Prices Above Inflation ArticleNov 1, 2023 Drug Companies Continue To Hike Prices Above Inflation New analysis makes clear that the Inflation Reduction Act’s inflation rebates should extend to the commercial market. Nov 1, 2023 Nicole Rapfogel
Following the Money: Untangling U.S. Prescription Drug Financing ReportOct 12, 2023 Following the Money: Untangling U.S. Prescription Drug Financing This report discusses how money flows through the pharmaceutical ecosystem and how policymakers should address high prices. Oct 12, 2023 Sam Hughes, Nicole Rapfogel